PeptideQC Global

Effective: 15 July 2026

Research-use-only disclaimer

Not for human or animal use. Products are supplied solely to qualified laboratories for lawful in-vitro or analytical research. They are not medicines, medical devices, diagnostics, food, cosmetics, household goods or consumer products.

No medical or veterinary advice

Website content is scientific and commercial information for professional evaluation only. It does not provide medical, veterinary, diagnostic, prescribing, dosing or treatment advice and must not be used as a clinical-trial substitute.

Investigational status

Retatrutide/LY3437943 is described as an investigational research molecule. References to published research, trial registries or analytical results do not state or imply regulatory approval, clinical availability, safety, efficacy or fitness for use in humans or animals.

No affiliation

PeptideQC Global and Metatron Marketing Ltd. are independent. They are not affiliated with, endorsed by or sponsored by Eli Lilly and Company, Brown University, any clinical-trial sponsor, regulator or publication. Any third-party names are used only for identification or source attribution.

Analytical evidence

Certificates and test reports apply only to the identified batch, sample, method and test date. They do not eliminate experimental, handling, contamination or suitability risks. Buyers must validate identity, concentration, method fitness and storage for their own lawful protocol.

Professional responsibility

The qualified buyer is responsible for risk assessment, trained personnel, facilities, PPE, storage, chain of custody, waste disposal, permits, import/export compliance and prevention of diversion. Suspected personal, dosing, therapeutic or animal-use inquiries will be rejected or escalated.

Information accuracy

We aim to keep content accurate but scientific, legal and regulatory information changes. No public webpage replaces the accepted quote, batch release documents or buyer’s independent professional and legal review.